BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, Armanfard N, Sagan SM, Jahanshahi-Anbuhi S. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection. Clin Microbiol Rev 2021;34:e00228-20. [PMID: 33980687 DOI: 10.1128/CMR.00228-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Junior AF, Azevedo E, Paes AT, Lima E, Campos Guerra JC, Ingham SJMN. Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study. BMC Geriatr 2022;22:132. [PMID: 35172759 DOI: 10.1186/s12877-022-02776-3] [Reference Citation Analysis]
2 Jian MJ, Perng CL, Chung HY, Chang CK, Lin JC, Yeh KM, Chen CW, Hsieh SS, Pan PC, Chang HT, Chang FY, Ho CL, Shang HS. Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan. Int J Infect Dis 2021;115:30-4. [PMID: 34843956 DOI: 10.1016/j.ijid.2021.11.034] [Reference Citation Analysis]
3 Sadiq Z, Safiabadi Tali SH, Jahanshahi-anbuhi S. Gold Tablets: Gold Nanoparticles Encapsulated into Dextran Tablets and Their pH-Responsive Behavior as an Easy-to-Use Platform for Multipurpose Applications. ACS Omega. [DOI: 10.1021/acsomega.1c07393] [Reference Citation Analysis]
4 Beleva N. Change in hospital admissions in dental diseases before and during the COVID-19 pandemic. Appl Nanosci. [DOI: 10.1007/s13204-021-02106-w] [Reference Citation Analysis]
5 Ruetalo N, Flehmig B, Schindler M, Pridzun L, Haage A, Reichenbächer M, Kirchner T, Kirchner T, Klingel K, Ranke MB, Normann A. Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL). Viruses 2021;13:2336. [DOI: 10.3390/v13122336] [Reference Citation Analysis]
6 Fajardo Á, Perbolianachis P, Ferreiro I, Moreno P, Moratorio G. Molecular accuracy vs antigenic speed: SARS-CoV-2 testing strategies. Current Opinion in Pharmacology 2022;62:152-8. [DOI: 10.1016/j.coph.2021.12.006] [Reference Citation Analysis]
7 Dergaa I, Abdelrahman H, Varma A, Yousfi N, Souissi A, Ghram A, Hammad AS, Musa ER, Taheri M, Irandoust K, Chtourou H, Rafiei MM, Ghasemi M, Farzian S; PHCC, Primary Health Care Corporation, Doha, Qatar, PHCC, Primary Health Care Corporation, Doha, Qatar, PHCC, Primary Health Care Corporation, Doha, Qatar, Research Laboratory “Sport Performance Optimization”, National Centre of Medicine and Science in Sport (CNMSS), Tunis, Tunisia, Research Laboratory “Sport Performance Optimization”, National Centre of Medicine and Science in Sport (CNMSS), Tunis, Tunisia, Research Laboratory “Sport Performance Optimization”, National Centre of Medicine and Science in Sport (CNMSS), Tunis, Tunisia, Hamad Bin Khalifa University, College of Health and Life Science, HMC, Hamad Medical Corporation, PO Box 3050, Doha, Qatar, Department of Sport Sciences, Imam Khomeini International University, Qazvin, Iran, Department of Sport Sciences, Imam Khomeini International University, Qazvin, Iran, Institut Supérieur du Sport et de l’éducation physique de Sfax, Université de Sfax, Sfax, Tunisia. Activité Physique, Sport et Santé, UR18JS01, Observatoire National du Sport, Tunis, Tunisia, Depratment of exercise physiology, Faculty of Physical Education & Sport Sciences, University of Tehran, kish International Campus, Department of Sport Sciences, Imam Khomeini International University, Qazvin, Iran, Department of Physical Education and Sport Sciences, Islamic Azad University, Qazvin Branch, Qazvin, Iran. COVID-19 Vaccination, Herd Immunity and The Transition Toward Normalcy: Challenges with The Upcoming Sports Events. Ann Appl Sport Sci 2021;9:0-0. [DOI: 10.52547/aassjournal.1032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nyaruaba R, Mwaliko C, Dobnik D, Neužil P, Amoth P, Mwau M, Yu J, Yang H, Wei H. Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks. Clin Microbiol Rev 2022;:e0016821. [PMID: 35258315 DOI: 10.1128/cmr.00168-21] [Reference Citation Analysis]
9 Gitman MR, Shaban MV, Paniz-Mondolfi AE, Sordillo EM. Laboratory Diagnosis of SARS-CoV-2 Pneumonia. Diagnostics (Basel) 2021;11:1270. [PMID: 34359353 DOI: 10.3390/diagnostics11071270] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Han Y, Yang J, He D, Feng Y, Liu X, Min Y, Fan S, Yin G, Hu D. Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer. Front Immunol 2022;13:855311. [DOI: 10.3389/fimmu.2022.855311] [Reference Citation Analysis]
11 Zhang X, Meng H, Liu H, Ye Q. Advances in laboratory detection methods and technology application of SARS-CoV-2. J Med Virol 2021. [PMID: 34854101 DOI: 10.1002/jmv.27494] [Reference Citation Analysis]
12 Scholtz A, Ramoji A, Silge A, Jansson JR, de Moura IG, Popp J, Sram JP, Armani AM. COVID-19 Diagnostics: Past, Present, and Future. ACS Photonics 2021;8:2827-38. [DOI: 10.1021/acsphotonics.1c01052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang Y, Li Z, Milon Essola J, Ge K, Dai X, He H, Xiao H, Weng Y, Huang Y. Biosafety materials: ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.03.010] [Reference Citation Analysis]
14 Patriquin G, Davidson RJ, Hatchette TF, Head BM, Mejia E, Becker MG, Meyers A, Sandstrom P, Hatchette J, Block A, Smith N, Ross J, LeBlanc JJ. Generation of False-Positive SARS-CoV-2 Antigen Results with Testing Conditions outside Manufacturer Recommendations: A Scientific Approach to Pandemic Misinformation. Microbiol Spectr 2021;9:e0068321. [PMID: 34668722 DOI: 10.1128/Spectrum.00683-21] [Reference Citation Analysis]
15 Nyaruaba R, Mwaliko C, Hong W, Amoth P, Wei H. SARS-CoV-2/COVID-19 Laboratory Biosafety Practices and Current Molecular Diagnostic Tools. J Biosaf Biosecur 2021. [PMID: 34746686 DOI: 10.1016/j.jobb.2021.10.001] [Reference Citation Analysis]
16 Mihaescu G, Chifiriuc MC, Vrancianu CO, Constantin M, Filip R, Popescu MR, Burlibasa L, Nicoara AC, Bolocan A, Iliescu C, Gradisteanu Pircalabioru G. Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses. Microorganisms 2021;9:2578. [PMID: 34946179 DOI: 10.3390/microorganisms9122578] [Reference Citation Analysis]
17 Gradisteanu Pircalabioru G, Iliescu FS, Mihaescu G, Cucu AI, Ionescu ON, Popescu M, Simion M, Burlibasa L, Tica M, Chifiriuc MC, Iliescu C. Advances in the Rapid Diagnostic of Viral Respiratory Tract Infections. Front Cell Infect Microbiol 2022;12:807253. [DOI: 10.3389/fcimb.2022.807253] [Reference Citation Analysis]
18 Biolo G, Fiotti N, Cominotto F, Di Girolamo FG, Panizon E, Altamura N, Casarsa C, Pipoli A, Giordano M, Torelli L, Mearelli F, Vinci P. Ruling Out Coronavirus Disease 2019 in Patients with Pneumonia: The Role of Blood Cell Count and Lung Ultrasound. J Clin Med 2021;10:3481. [PMID: 34441777 DOI: 10.3390/jcm10163481] [Reference Citation Analysis]
19 Wu K, Chugh VK, D Krishna V, di Girolamo A, Wang YA, Saha R, Liang S, Cheeran MC, Wang JP. One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase. ACS Appl Mater Interfaces 2021;13:44136-46. [PMID: 34499464 DOI: 10.1021/acsami.1c14657] [Reference Citation Analysis]
20 Patriquin G, LeBlanc JJ, Williams C, Hatchette TF, Ross J, Barrett L, Davidson R. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer. Microbiol Spectr 2022;:e0245521. [PMID: 35171010 DOI: 10.1128/spectrum.02455-21] [Reference Citation Analysis]
21 Dai G, Duan J, Zheng L, He M, Dai Y, Zhang M, Chu S. Comparison of lung image quality between CT Ark and Brilliance 64 CT during COVID-19. BMC Med Imaging 2021;21:192. [PMID: 34903187 DOI: 10.1186/s12880-021-00720-2] [Reference Citation Analysis]
22 Belu A, Trandafir LM, Țarcă E, Cojocaru E, Frăsinariu O, Stârcea M, Moscalu M, Tiutiuca RC, Luca AC, Galaction A. Variations in Biochemical Values under Stress in Children with SARS-CoV-2 Infection. Diagnostics 2022;12:1213. [DOI: 10.3390/diagnostics12051213] [Reference Citation Analysis]
23 Li J, Wang M, Jia R, Ma Z, Zhang X, Li J, Xiao X, Zhou Y, Wang Q. Graphene-Coated Iron Nitride Streptavidin Magnetic Beads: Preparation and Application in SARS-CoV-2 Enrichment. Magnetochemistry 2022;8:41. [DOI: 10.3390/magnetochemistry8040041] [Reference Citation Analysis]
24 Li M, Zhao J, Zhang H, Liu J, Fan X, Bai X, Lu Z. Integrated mobile container PCR laboratory (IMCPL): A novel strategy to reduce unnecessary rapid antigen testing. J Infect 2021:S0163-4453(21)00476-X. [PMID: 34536424 DOI: 10.1016/j.jinf.2021.09.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Saberian P, Falahi S, Baratloo A, Hasani-Sharamin P, Ahmadzade A, Jamshididana M, Ahmadihatam Z. Changes in COVID-19 IgM and IgG antibodies in emergency medical technicians (EMTs). Am J Emerg Med 2021;52:59-63. [PMID: 34864629 DOI: 10.1016/j.ajem.2021.11.019] [Reference Citation Analysis]
26 Mostafa GA, Ibrahim HM, Al Sayed Shehab A, Gendy YGE, Aly DMM, Shousha GAH. Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2. Eur J Pediatr 2022. [PMID: 35233677 DOI: 10.1007/s00431-022-04398-8] [Reference Citation Analysis]
27 Sanchez AO, Ochoa AR, Hall SL, Voelker CR, Mahoney RE, McDaniel JS, Blackburn A, Asin SN, Yuan TT. Comparison of next generation diagnostic systems (NGDS) for the detection of SARS-CoV-2. J Clin Lab Anal 2022;:e24285. [PMID: 35174538 DOI: 10.1002/jcla.24285] [Reference Citation Analysis]
28 Shen X, Wang J, Li J, He A, Liu H, Ma X. Field Validation of a Rapid Recombinase Aided Amplification Assay for SARS-CoV-2 RNA at Customs - Zhejiang Province, China, January 2021. China CDC Wkly 2021;3:973-6. [PMID: 34804630 DOI: 10.46234/ccdcw2021.236] [Reference Citation Analysis]